« Back to Record
Citation APA

Van Mieghem, W., Billiouw, J. M., Brohet, C., Dupont, A., Gazagnes, M.-D., Heller, F. R., Krezsinski, J. M., Missault, L., Persu, A., Piérard, L. A., Rottiers, R., Vanhooren, G., Vervaet, P., & Herman, A. (2010). Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend. Acta clinica Belgica (Ed. multilingue), 65(2), 107-114.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/169258

Van Mieghem, W., Billiouw, J. M., Brohet, C., Dupont, A., Gazagnes, M.-D., Heller, F. R., Krezsinski, J. M., Missault, L., Persu, A., Piérard, L. A., Rottiers, R., Vanhooren, G., Vervaet, P., & Herman, A. (2010). Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend. Acta clinica Belgica (Ed. multilingue), 65(2), 107-114.